94 results on '"Bourboulia, Dimitra"'
Search Results
2. Second international symposium on the chaperone code, 2023
3. Second Virtual International Symposium on Cellular and Organismal Stress Responses, September 8–9, 2022
4. Catalytic inhibitor of Protein Phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex II in kidney cancer
5. Activation of autophagy depends on Atg1/Ulk1-mediated phosphorylation and inhibition of the Hsp90 chaperone machinery
6. PhosY-secretome profiling combined with kinase-substrate interaction screening defines active c-Src-driven extracellular signaling
7. Hsp90 chaperone code and the tumor suppressor VHL cooperatively regulate the mitotic checkpoint
8. The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect
9. Extracellular Phosphorylation of TIMP-2 by Secreted c-Src Tyrosine Kinase Controls MMP-2 Activity
10. LIM Domains-Containing Protein 1 (LIMD1), a Tumor Suppressor Encoded at Chromosome 3p21.3, Binds pRB and Represses E2F-Driven Transcription
11. Structural and functional basis of protein phosphatase 5 substrate specificity
12. Viral Coinfections among African Children Infected with Human Immunodeficiency Virus Type 1
13. Epichaperomics reveals dysfunctional chaperone protein networks.
14. Endogenous Angiogenesis Inhibitor Blocks Tumor Growth via Direct and Indirect Effects on Tumor Microenvironment
15. Transformation of Human Mesenchymal Stem Cells Increases Their Dependency on Oxidative Phosphorylation for Energy Production
16. FNIP CO-CHAPERONES PROTECT THE TUMOR SUPPRESSOR FLCN FROM UBIQUITINATION AND DEGRADATION IN THE PROTEASOME: MP85-13
17. Seroprevalence of Human Herpesvirus 8 and Its Association With Kaposi Sarcoma in Brazil
18. Serologic Evidence of Human Herpesvirus 8 Transmission by Homosexual but Not Heterosexual Sex
19. Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer.
20. TRAP1 Chaperones the Metabolic Switch in Cancer.
21. Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity
22. Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma
23. Kaposi Sarcoma Herpesvirus: Update
24. Antibodies against human herpesvirus 8 in black South African patients with cancer
25. Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia
26. The 2021 FASEB Virtual Catalyst Conference on Extracellular and Organismal Proteostasis in Health and Disease, February 3-4, 2021.
27. Activation of autophagy depends on Atg1/Ulk1-mediated phosphorylation and inhibition of the Hsp90 chaperone machinery.
28. Serologic Evidence for Mother-to-Child Transmission of Kaposi Sarcoma-Associated Herpesvirus Infection
29. Decrypting the chaperone code.
30. Viral coinfections among African children infected with human immunodeficiency virus type 1. (HIV/AIDS: Brief Report)
31. Extracellular HSP90 warms up integrins for an irisin workout.
32. Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study
33. Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90–Client Interactions.
34. Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients.
35. Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer.
36. HHV-8 peripheral-blood viral load and the titer of antibodies against HHV-8
37. A specialized Hsp90 co-chaperone network regulates steroid hormone receptor response to ligand.
38. Asymmetric Hsp90 N Domain SUMOylation Recruits Aha1 and ATP-Competitive Inhibitors.
39. Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells.
40. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
41. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.
42. Kaposi's Sarcoma-Associated Herpesvirus Cytotoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes.
43. Risk factors for Kaposi's sarcoma: A case-control study of HIV-seronegative people in Uganda.
44. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
45. Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
46. Viral Coinfections among African Children Infected with Human Immunodeficiency Virus Type 1.
47. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis.
48. Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90.
49. PD46-11 PHOSPHORYLATION AND UBIQUITINATION REGULATE PROTEIN PHOSPHATASE-5 ACTIVITY AND ITS PROSURVIVAL ROLE IN KIDNEY CANCER.
50. MP88-13 TUMOR SUPPRESSOR TSC1 IS A NEW HSP90 COCHAPERONE THAT FACILITATES FOLDING OF KINASE AND NON-KINASE CLIENTS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.